← Back to Search

Fluid Intake App for Obesity

N/A
Waitlist Available
Led By Michael Rocco, MD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Access to a smartphone for use of the app and comfort with using apps on a regular basis
Access to a smartphone running under either iOS or Android operating systems
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights

Study Summary

This trial is designed to test the safety and efficacy of an app that would help hemodialysis patients track their fluid intake to help prevent interdialytic weight gain.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You need to have a smartphone and be comfortable using apps regularly.
Select...
You have a smartphone that runs on either iOS or Android operating systems.
Select...
You are able to understand and use the fluid management app.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Amount of fluid consumed
Amount of interdialytic weight gain
Secondary outcome measures
Number of days that the app was used
Number of days that the app was used by day of the week
Number of days that the app was used by dialysis or non-dialysis days
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: VanguardExperimental Treatment2 Interventions
Participants in this arm will use the fluid intake app and take a survey to test the fluid intake monitoring app for both safety and design issues.

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,230 Previous Clinical Trials
1,001,725 Total Patients Enrolled
38 Trials studying Obesity
5,747 Patients Enrolled for Obesity
Danone ResearchIndustry Sponsor
53 Previous Clinical Trials
13,440 Total Patients Enrolled
Michael Rocco, MDPrincipal InvestigatorWake Forest University Health Sciences
2 Previous Clinical Trials
43 Total Patients Enrolled

Media Library

Survey Clinical Trial Eligibility Overview. Trial Name: NCT03759847 — N/A
Obesity Research Study Groups: Vanguard
Obesity Clinical Trial 2023: Survey Highlights & Side Effects. Trial Name: NCT03759847 — N/A
Survey 2023 Treatment Timeline for Medical Study. Trial Name: NCT03759847 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
~5 spots leftby Mar 2025